Skip to main content

CERT

Stock
Health Care
Health Information Services

Performance overview

CERT Price
Price Chart

Forward-looking statistics

Beta
0.75
Risk
45.72%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Company info

SectorHealth Care
IndustryHealth Information Services
Employees1K
Market cap$2.7B

Fundamentals

Enterprise value$2.0B
Revenue$394.5M
Revenue per employee
Profit margin-0.67%
Debt to equity28.51

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.02
Dividend per share
Revenue per share$2.45
Avg trading volume (30 day)$20M
Avg trading volume (10 day)$20M
Put-call ratio

Macro factor sensitivity

Growth+2.1
Credit+3.4
Liquidity-2.6
Inflation-2.9
Commodities+1.7
Interest Rates-1.5

Valuation

Dividend yield0.00%
PEG Ratio22.66
Price to sales4.66
P/E Ratio22.66
Enterprise Value to Revenue5.14
Price to book1.69

Upcoming events

Next earnings dayNovember 7, 2024
Next dividend day
Ex. dividend day

News

Will Certara (CERT) Beat Estimates Again in Its Next Earnings Report?

Certara (CERT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research (July 11, 2025)
Certara Unveils $100 Million Buyback Plan In Better-Than-Expected Preliminary Earnings Report

Certara, Inc. CERT on Monday announced expected revenue and bookings for the first quarter.

Benzinga (April 14, 2025)
Final Trade: CERT, XLE, DAL, OKTA

The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.

CNBC Television (January 11, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free